Welcome to LookChem.com Sign In|Join Free
  • or
C20H22N2O5 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1048685-07-9

Post Buying Request

1048685-07-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1048685-07-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1048685-07-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,8,6,8 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1048685-07:
(9*1)+(8*0)+(7*4)+(6*8)+(5*6)+(4*8)+(3*5)+(2*0)+(1*7)=169
169 % 10 = 9
So 1048685-07-9 is a valid CAS Registry Number.

1048685-07-9Downstream Products

1048685-07-9Relevant academic research and scientific papers

Intramolecular Friedel-Crafts reaction of indoles with carbonyl groups: A simple synthesis of 3- and 4-substituted β-carbolin-1-ones

Cincinelli, Raffaella,Dallavalle, Sabrina,Merlini, Lucio

experimental part, p. 1309 - 1312 (2009/04/06)

The intramolecular Friedel-Crafts reaction of indole-2-carboxylic acid β-oxoamides catalyzed by trifluoroacetic acid or InCl3, is a convenient method for the synthesis of 3-aryl-, 4-aryl-, and 4-alkyl-β-carbolin-1-ones. Georg Thieme Verlag Stuttgart.

Synthesis, modeling, and RET protein kinase inhibitory activity of 3- and 4-substituted β-carbolin-1-ones

Cincinelli, Raffaella,Cassinelli, Giuliana,Dallavalle, Sabrina,Lanzi, Cinzia,Merlini, Lucio,Botta, Maurizio,Tuccinardi, Tiziano,Martinelli, Adriano,Penco, Sergio,Zunino, Franco

scheme or table, p. 7777 - 7787 (2009/11/30)

A series of β-carbolin-2-ones and 3,10-dihydro-2H-azepino[3,4-b]indol- 1-ones have been designed, synthesized, and evaluated as RET protein kinase inhibitors on the basis of their structural similarity with the prototype indolin-2-one RPI-1. Some β-carbolin-2-ones (structure 2) showed an ability to inhibit RET enzymatic activity in vitro and proliferation of RETC634R oncogene-transformed NIH3T3 cells comparable to that of the reference compound. The docking analysis of the interaction of these compounds with the crystallographic structure of RET tyrosine kinase domain suggested a new binding interaction scheme different from the one proposed during their design. The rigid structure of the compounds of this series represents a new scaffold with potential advantages in the design of RET protein kinase inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1048685-07-9